CompoAtlas

CoEnzyme B Complex With Alpha Lipoic Acid And CoQ10

On sale on the US market (according to the DSLD)

Protocol For Life Balance, food supplement from the US market

CoEnzyme B Complex With Alpha Lipoic Acid And CoQ10 (Protocol For Life Balance), a food supplement au code-barres 707359104051, is described by its US market label. The French and European rules we can apply to this label flag no particular point. Doses of folates, niacine are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

If this product were sold in France

No point flagged by the rules we apply.

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
Protocol For Life Balance
Barcode
707359104051
Form
Tablet
One serving
2 tablets
Servings
up to 1 serving per day
Other ingredients (in English, as written)
Cellulose, Silica, Magnesium Stearate, Croscarmellose Sodium, Enteric Coating
Ingredient (as written, in English)CategoryPer serving
Vitamin CVitamin60 mg
ThiaminVitamin50 mg
RiboflavinVitamin50 mg
NiacinVitamin100 mg
Vitamin B-6Vitamin50 mg
FolateVitamin400 µg
Vitamin B12Vitamin250 µg
BiotinVitamin300 µg
Pantothenic AcidVitamin50 mg
BetaineOther substance50 mg
Alpha Lipoic AcidOther substance50 mg
CholineVitamin25 mg
PABAOther substance25 mg
InositolOther substance30 mg
CoQ10Other substance400 µg

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Betaine
    Read the warning, when it applies and the studies cited

    BETAINE / BETAINE HYDROCHLORIDE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products containing Betaine hydrochloride (as a medicinal ingredient or as a source ingredient).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a peptic ulcer or excess stomach acid (RSC 2024; Hendler and Rorvik 2008).

    Sources cited by Health Canada (2)
    • Hendler SS, Rorvik DM. PDR® for Nutritional Supplements, 2nd edition. Thomson Reuters. Physicians' Desk References Inc., NJ; 2008.
    • RSC 2024: Royal Society of Chemistry: The Merck Index Online [Accessed 2024 June 20]. Available from: https://merckindex.rsc.org/

    Applies to products providing 600 milligrams or more of Betaine or 780 milligrams or more of Betaine hydrochloride as a medicinal ingredient, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have high cholesterol (Olthof et al. 2005; Swab et al. 2002).

    Sources cited by Health Canada (2)
    • Olthof MR, van Vliet T, Verhoef P, Zock PL, Katan MB. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in health humans. PLoS Medicine 2005;2(5):e135. PubMed Randomised trial
    • Swab U, Torronen A, Toppinen L, Alfthan G, Saarinen M, Aro A, Uusitupa M. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. American Journal of Clinical Nutrition 2002;76:961-967.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : Protocol For Life Balance

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “CoEnzyme B Complex With Alpha Lipoic Acid And CoQ10 (Protocol For Life Balance): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/707359104051-coenzyme-b-complex-with-alpha-lipoic-acid-and-coq10-protocol, updated 23 December 2016.

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line